Man Group’s Cardiovascular Systems, Inc. CSII Stock Holding History

Man Group’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-24,704	Closed	-$558K	–	2494
2022 Q1	$558K	Buy	24,704 +3,700	+18%	+$71.8K	﹤0.01%	1547
2021 Q4	$394K	Sell	21,004 -2,945	-12%	-$78.6K	﹤0.01%	1601
2021 Q3	$787K	Buy	+23,949	New	+$893K	﹤0.01%	1410
2021 Q2	–	Sell	-8,371	Closed	-$321K	–	2139
2021 Q1	$321K	Sell	8,371 -16,550	-66%	-$704K	﹤0.01%	1609
2020 Q4	$1.09M	Buy	+24,921	New	+$938K	﹤0.01%	1390
2020 Q1	–	Sell	-90,321	Closed	-$4.39M	–	1965
2019 Q4	$4.39M	Sell	90,321 -14,482	-14%	-$659K	0.01%	1042
2019 Q3	$4.98M	Sell	104,803 -46,087	-31%	-$2.17M	0.02%	877
2019 Q2	$6.48M	Sell	150,890 -36,649	-20%	-$1.42M	0.02%	843
2019 Q1	$7.25M	Buy	187,539 +4,384	+2%	+$149K	0.03%	730
2018 Q4	$5.22M	Sell	183,155 -26,149	-12%	-$831K	0.02%	747
2018 Q3	$8.19M	Buy	209,304 +65,078	+45%	+$2.41M	0.03%	726
2018 Q2	$4.67M	Sell	144,226 -18,844	-12%	-$519K	0.02%	986
2018 Q1	$3.58M	Buy	+163,070	New	+$3.92M	0.02%	1032

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Man Group's CSII Position: Q2 2022 in Review

Man Group sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2022, closing a stake of 24,704 shares — an estimated $558K sold.

Man Group first reported a position in CSII in Q1 2018 and held it in 13 quarters. The position peaked at $8.19M in Q3 2018. 158 funds tracked by Wall St. Rank hold CSII as of Q2 2022.

Man Group reported no remaining Cardiovascular Systems, Inc. position as of Q2 2022 after selling out during the quarter.
Man Group sold 24,704 Cardiovascular Systems, Inc. shares in Q2 2022, an estimated $558K.
Man Group first reported a position in Cardiovascular Systems, Inc. in Q1 2018 and held it in 13 quarters.
Man Group's Cardiovascular Systems, Inc. position peaked at $8.19M in Q3 2018.
158 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2022.

Based on Man Group's 13F filing for Q2 2022, filed 15 Aug 2022.